Evidence map›Paper›PMID 12566542›Full record

ArticleThe Journal of general physiology2003

Molecular action of lidocaine on the voltage sensors of sodium channels.

Michael F Sheets, Dorothy A Hanck

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of general physiology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 114 citations in OpenAlex.

  1. Trial
  2. Oxaliplatin-induced peripheral neuropathy: from pathogenesis to treatment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Eugenol and lidocaine inhibit voltage-gated NaFrontiers in pharmacology · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. [Progress on the roles of glia in postoperative cognitive dysfunction].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2020
    Review
  12. Article
  13. A Molecularly Detailed NaJACC. Basic to translational science · 2019
    Article
  14. Functional and Mechanistic Neurotoxicity Profiling Using Human iPSC-Derived Neural 3D Cultures.Toxicological sciences : an official journal of the Society of Toxicology · 2019
    Article
  15. Article
  16. Propofol inhibits prokaryotic voltage-gated NaThe Journal of general physiology · 2018
    Article
  17. Review
  18. Regulation of NaThe Journal of general physiology · 2017
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Michael F SheetsThe Nora Eccles Harrison Cardiovascular Research and Training Institute, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84112, USA. michael@cvrti.utah.edu
Dorothy A Hanck
University of Chicago · USUniversity of Utah · US

Funding

PHARMACOLOGY OF CARDIAC SODIUM CHANNEL MODIFIERSR01HL044630 · NHLBI · UNIVERSITY OF UTAH · PI SHEETS, MICHAEL F · 1996 to 2008
$2.7M
NHLBI NIH HHS HL-R01-44630
6 · The paper itself

Abstract

Block of sodium ionic current by lidocaine is associated with alteration of the gating charge-voltage (Q-V) relationship characterized by a 38% reduction in maximal gating charge (Q(max)) and by the appearance of additional gating charge at negative test potentials. We investigated the molecular basis of the lidocaine-induced reduction in cardiac Na channel-gating charge by sequentially neutralizing basic residues in each of the voltage sensors (S4 segments) in the four domains of the human heart Na channel (hH1a). By determining the relative reduction in the Q(max) of each mutant channel modified by lidocaine we identified those S4 segments that contributed to a reduction in gating charge. No interaction of lidocaine was found with the voltage sensors in domains I or II. The largest inhibition of charge movement was found for the S4 of domain III consistent with lidocaine completely inhibiting its movement. Protection experiments with intracellular MTSET (a charged sulfhydryl reagent) in a Na channel with the fourth outermost arginine in the S4 of domain III mutated to a cysteine demonstrated that lidocaine stabilized the S4 in domain III in a depolarized configuration. Lidocaine also partially inhibited movement of the S4 in domain IV, but lidocaine's most dramatic effect was to alter the voltage-dependent charge movement of the S4 in domain IV such that it accounted for the appearance of additional gating charge at potentials near -100 mV. These findings suggest that lidocaine's actions on Na channel gating charge result from allosteric coupling of the binding site(s) of lidocaine to the voltage sensors formed by the S4 segments in domains III and IV.

Indexed as

Anesthetics, LocalCell LineHumansIon Channel GatingLidocaineMutagenesis, Site-DirectedPatch-Clamp TechniquesProtein Structure, TertiarySodium ChannelsAnesthetics, LocalLidocaineSodium Channels

Identifiers

PMID12566542
PMCPMC2217326
OpenAlexW2102491071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.